Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia



Status:Completed
Conditions:High Cholesterol, Metabolic
Therapuetic Areas:Cardiology / Vascular Diseases, Pharmacology / Toxicology
Healthy:No
Age Range:18 - 79
Updated:5/3/2014
Start Date:November 2012
End Date:June 2013
Contact:Ryan Childers
Email:Ryan.Childers@mxns.com

Use our guide to learn which trials are right for you!

The purpose of this study is to investigate the efficacy and safety of DHA-O to lower
elevated triglyceride levels in healthy adults with hypertriglyceridemia.


Inclusion Criteria:

- ages 18-79

- fasting TG levels, 150-499 mg/dL

- baseline DHA intake <200mg/d

- active and in good health

Exclusion Criteria:

- recent diagnosis of CHD or history of revascularization within 6mos of study

- use of lipid altering medications (other than stable statins)

- use of anticoagulants

- use of omega-3 products within 4 weeks of screening

- serum AST/ALT >1.5x ULN and/or creatinine >1.5 mg/dL at screening

- lipid altering foods or supplements

- women who are pregnant or of childbearing potential not using adequate birth control

- current use or history of drug or alcohol abuse

- inability to swallow capsules
We found this trial at
1
site
Addison, Illinois 60101
?
mi
from
Addison, IL
Click here to add this to my saved trials